ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.63
-0.02 (-0.35%)
Jun 8, 2026, 4:00 PM EDT - Market closed
ImageneBio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -47.35 | -45.35 | -36.57 | -68.17 | -68.77 | -34.12 |
Depreciation & Amortization | 0.65 | 1.03 | 1.53 | 1.02 | 0.75 | 0.54 |
Stock-Based Compensation | 15.36 | 15.39 | - | 7.63 | 7.53 | 5.18 |
Other Adjustments | 0.58 | 0.27 | 15.24 | 1.44 | 1.52 | 1.17 |
Changes in Accounts Payable | -2.96 | -2.82 | -0.52 | -2.87 | -0.29 | 0.36 |
Changes in Accrued Expenses | -8.44 | -9.1 | -1.06 | -7.66 | 2.23 | 1.3 |
Changes in Unearned Revenue | - | -0.65 | 0.51 | -9.16 | -15.62 | -30.99 |
Changes in Other Operating Activities | -6.33 | -6.62 | -0.45 | -1.98 | -1.46 | -3.71 |
Operating Cash Flow | -52.08 | -47.84 | -21.32 | -79.74 | -74.11 | -60.25 |
Capital Expenditures | - | - | - | -0.41 | -1.43 | -1.76 |
Sale of Property, Plant & Equipment | - | - | 0.97 | - | - | - |
Purchases of Investments | -21.34 | -10.4 | - | -90.05 | -216.34 | - |
Proceeds from Sale of Investments | -22.79 | 9.8 | 10.15 | 154.61 | 118.49 | - |
Other Investing Activities | -7.5 | -5.22 | - | - | - | - |
Investing Cash Flow | -6.25 | -5.81 | 11.12 | 64.14 | -99.28 | -1.76 |
Long-Term Debt Issued | - | 15 | 7.5 | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | 15 | 7.5 | - | - | - |
Issuance of Common Stock | 0.04 | 71.18 | - | 37.56 | 1.1 | 131.88 |
Repurchase of Common Stock | - | - | - | -0.66 | - | - |
Net Common Stock Issued (Repurchased) | 0.04 | 71.18 | - | 36.89 | 1.1 | 131.88 |
Issuance of Preferred Stock | - | - | - | - | - | -0.15 |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | - | -0.15 |
Other Financing Activities | -3.28 | 49.29 | -0.59 | 39.09 | - | - |
Financing Cash Flow | -3.24 | 135.47 | 6.91 | 75.98 | 1.1 | 131.74 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.05 | 0.6 | 0.09 | - | - | - |
Net Cash Flow | -9.04 | 82.41 | -3.2 | 60.38 | -172.3 | 69.73 |
Free Cash Flow | -52.08 | -47.84 | -21.32 | -80.16 | -75.54 | -62.01 |
FCF Margin | - | -5980.50% | -609.11% | -875.08% | -483.67% | -200.14% |
Free Cash Flow Per Share | -6.55 | -9.82 | -4.38 | -23.05 | -25.05 | -26.59 |
Levered Free Cash Flow | -60.23 | -55.55 | -40.87 | -89.23 | -84.58 | -68.36 |
Unlevered Free Cash Flow | -72.88 | -66.23 | -37 | -96.66 | -86.72 | -68.39 |